Imagin Medical Past Earnings Performance

Past criteria checks 0/6

Imagin Medical has been growing earnings at an average annual rate of 7.9%, while the Medical Equipment industry saw earnings growing at 13.5% annually.

Key information

7.9%

Earnings growth rate

21.9%

EPS growth rate

Medical Equipment Industry Growth-19.2%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Jun 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Imagin Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:IME Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 230-311
31 Mar 230-112
31 Dec 220-112
30 Sep 220-212
30 Jun 220-622
31 Mar 220-1122
31 Dec 210-1222
30 Sep 210-1122
30 Jun 210-421
31 Mar 210-421
31 Dec 200-422
30 Sep 200-422
30 Jun 200-523
31 Mar 200-623
31 Dec 190-522
30 Sep 190-422
30 Jun 190-532
31 Mar 190-641
31 Dec 180-861
30 Sep 180-871
30 Jun 180-661
31 Mar 180-540
31 Dec 170-220
30 Sep 170-210
30 Jun 170-210
31 Mar 170-220
31 Dec 160-320
30 Sep 160-220
30 Jun 160-210

Quality Earnings: IME is currently unprofitable.

Growing Profit Margin: IME is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IME is unprofitable, but has reduced losses over the past 5 years at a rate of 7.9% per year.

Accelerating Growth: Unable to compare IME's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IME is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: IME's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.